UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 101 - 150 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

New therapies for non-muscle-invasive bladder cancer - Abstract
Wednesday, 07 October 2009
Department of Urology, National University Hospital, Singapore, Singapore.
read more

Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy - Abstract
Wednesday, 07 October 2009
Department of Urology, Graduate School of Medicine, Yamaguchi University, Yamaguchi, Japan.
read more

Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure - Abstract
Wednesday, 07 October 2009
Department of Biomedical Sciences, University of Portsmouth, Portsmouth.
read more

Cardiac history and risk of post-cystectomy cardiac complications - Abstract
Tuesday, 06 October 2009
Department of Urology, M.D. Anderson Cancer Center, The University of Texas, Texas, USA.
read more

Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles - Abstract
Tuesday, 06 October 2009
Department of Urology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
read more

Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance - Abstract
Tuesday, 06 October 2009
Department of Urology, Pitié-Salpêtrière and Tenon Hospitals, GHU Est, AP-HP, Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France.
read more

Genitourinary tumor following kidney transplantation: a multicenter study - Abstract
Tuesday, 06 October 2009
Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
read more

AUA NY 2009 - Improving survival for patients with bladder cancer - Multimedia Presentation
Monday, 05 October 2009
SEWARD, AK, USA - Presented by Ralph de Vere White, MD at the 107th Annual Meeting of the AUA - New York Section - August 19 - 26, 2009, Seward, Alaska, USA
Login to read more...

Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy - Abstract
Monday, 05 October 2009
Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California.
read more

Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma - Abstract
Monday, 05 October 2009
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada.
read more

Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with Bacillus Calmette-Guerin-refractory bladder cancer - Abstract
Monday, 05 October 2009
The James Buchanan Brady Urologic Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
read more

Urologic oncology services expanded at Cancer Institute of NJ
Monday, 05 October 2009
NEW BRUNSWICK, NJ, USA (News Release) - October 2, 2009
read more

URS 2009 - Prediction of response to intravesical BCG by genome-wide cDNA microarray analysis: in primary T1 bladder cancer - Slide Presentation
Friday, 02 October 2009
NORTH QUEENSLAND, AUSTRALIA (UroToday.com) - Presented by Wun-Jae Kim, MD at the Urological Research Society (URS) - 25th Annual Meeting - August 10 - 14, 2009
Login to read more...

URS 2009 - Heme oxygenase-1 expression correlates with chemo-resistance against intravesical administration of anthracycline antitumor drugs in non-muscle invasive bladder cancer - Slide Presentation
Friday, 02 October 2009
NORTH QUEENSLAND, AUSTRALIA (UroToday.com) - Presented by Yoshihiko Hirao, MD at the Urological Research Society (URS) - 25th Annual Meeting - August 10 - 14, 2009
Login to read more...

Bladder cancer in cancer patients: population-based estimates from a large Swedish study - Abstract
Friday, 02 October 2009
Institute of Medical Biometry and Informatics (IMBI), University Hospital Heidelberg, 69120 Heidelberg, Germany.
read more

Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder - Abstract
Friday, 02 October 2009
Clinical Pathology Department, Tanta University, Tanta, Egypt.
read more

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: The CUETO scoring model - Abstract
Friday, 02 October 2009
Department of Urology, Hospital Central of Asturias, University of Oviedo, Oviedo, Spain.
read more

URS 2009 - Invasive TCC in the elderly: Radical cystectomy? - Slide Presentation
Thursday, 01 October 2009
NORTH QUEENSLAND, AUSTRALIA (UroToday.com) - Presented by Oliver Reich, MD at the Urological Research Society (URS) - 25th Annual Meeting - August 10 - 14, 2009
Login to read more...

The west midlands bladder cancer prognosis programme: rationale and design - Abstract
Thursday, 01 October 2009
Department of Public Health, Epidemiology and Biostatistics, University of Birmingha, Birmingham, UK.
read more

Bladder cancer in spinal cord injury patients - Abstract
Thursday, 01 October 2009
Department of Urology, University of California, Irvine, CA, USA.
read more

BJUI Mini Reviews - Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract
Wednesday, 30 September 2009
This review examines DNA methylation, an important epigenetic mechanism of gene regulation that plays essential roles in urothelial cell tumour initiation and progression.
Login to read more...

Health information quality on the Internet in urological oncology: A multilingual longitudinal evaluation - Abstract
Wednesday, 30 September 2009
Division of Urology, University Health Network (UHN), University of Toronto, Toronto, Canada
read more

Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria - Abstract
Wednesday, 30 September 2009
We determine the utility of serial urinary cytologies in patients presenting with microscopic hematuria who were evaluated with upper and lower urinary tract studies to rule out a malignancy.
read more

Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy - Abstract
Wednesday, 30 September 2009
Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan
read more

C2R 2009 - Case Discussions - Session Highlights
Tuesday, 29 September 2009
MONTREAL, QC, CANADA (UroToday.com) - Larry Goldenberg, MD, presented an interesting case of BPH.
Login to read more...

An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer - Abstract
Tuesday, 29 September 2009
Division of Urology, Department of Surgery, University of Toronto, University Health Network, Toronto, Canada
read more

Understanding the role of smoking in the aetiology of bladder cancer - Abstract
Tuesday, 29 September 2009
Epsom and St Helier University Hospitals NHS Trust, Surrey
read more

Editorial - Flexible and rigid cystoscopy in women
Wednesday, 23 September 2009
BERKELEY, CA (UroToday.com) - In this single blinded, prospective study, 36 women requiring cystoscopy were randomized to either rigid or flexible cystoscopy;
Login to read more...

DGU 2009 - Comparison of antirefluxive and refluxive ureteral implantation techniques into ileal neobladder in a single center of excellence - Session Highlights
Monday, 21 September 2009
DRESDEN, GERMANY (UroToday.com) - The authors reviewed 1,013 patients who had undergone radical cystectomy for urothelial cancer of the bladder with regard to ureteral implantation techniques into ileal neobladder.
Login to read more...

DGU 2009 - Large series of patients with T1G3 urothelial cancer of the bladder - Session Highlights
Monday, 21 September 2009
DRESDEN, GERMANY (UroToday.com) - A total of 1,136 patients with T1G3 urothelial cancer of the bladder that had undergone radical cystectomy and lymph node dissection were analyzed in a retrospective manner.
Login to read more...

DGU 2009 - Intravesical Gemcitabine does not improve the recurrence rate in non muscle-invasive urothelial cancer of the bladder - Session Highlights
Monday, 21 September 2009
DRESDEN, GERMANY (UroToday.com) - In a prospective phase-III trial, 355 patients with suspected primary or recurrent urothelial cancer of the bladder were randomized to receive transurethral resection followed by intravesical gemcitabine (2000 mg/100 mls. normal saline, arm A)
Login to read more...

DGU 2009 - Photodynamic diagnosis (PDD) with Hexvix improves detection, resection and recurrence-free survival in patients with non muscle-invasive urothelial cancer of the bladder
Monday, 21 September 2009
DRESDEN, GERMANY (UroToday.com) - In a prospective phase-III trial at 28 centers in Europe and the US, 766 patients with multiple or recurrent urothelial cancer of the bladder were randomized to undergo white light cystoscopy (arm a) or white light cystoscopy followed by PDD with Hexvix (arm B).
Login to read more...

DGU 2009 - Lymphovascular invasion is an independent risk factor in patients with organ-confined urothelial cancer of the bladder: Multicenter validation in Germany - Session Highlights
Monday, 21 September 2009
DRESDEN, GERMANY (UroToday.com) - In a retrospective analysis of 1,099 patients who had undergone radical cystectomy for urothelial cancer the impact of lymphovascular invasion on relapse-free survival, disease-free survival ad overall survival was calculated.
Login to read more...

Flexible and rigid cystoscopy in women - Abstract
Monday, 21 September 2009
Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA
read more

Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors - Abstract
Monday, 21 September 2009
Department of Urology, Weill Cornell Medical Center, New York.
read more

Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: Recommendations of the Society of Urologic Robotic Surgeons - Abstract
Monday, 21 September 2009
Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois 60637, USA
read more

Medical societies push standards for robotic surgery
Friday, 18 September 2009
CHICAGO, IL, USA (News Release) - September 18, 2009
read more

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? - Abstract
Friday, 18 September 2009
Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
read more

Synergistic potentiation of interferon activity with maitake mushroom d-fraction on bladder cancer cells - Abstract
Friday, 18 September 2009
Department of Urology, New York Medical College, Valhalla, NY, USA.
read more

Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy - Abstract
Thursday, 17 September 2009
Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
read more

Laparoscopic radical cystectomy with vaginal specimen extraction: Case report - Abstract
Monday, 14 September 2009
Hospital Alemán, Buenos Aires, Argentina.
read more

HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management - Abstract
Monday, 14 September 2009
Chronic human immunodeficiency virus (HIV) infection is associated with an increased incidence of Non-Acquired Immunodeficiency Syndrome (non-AIDS) defining cancers.
read more

Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review - Abstract
Friday, 11 September 2009
Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University (MC), Tehran, Iran.
read more

Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases - Abstract
Friday, 11 September 2009
Hospital General Universitario Gregorio Marañón, Madrid, España.
read more

Predicting recurrence and progression in non-muscle-invasive bladder cancer using European organization of research and treatment of cancer risk tables - Abstract
Friday, 11 September 2009
Department of Surgery, Aga Khan University, Karachi, Pakistan.
read more

Lead concentration in the bladder tissue and blood of patients with bladder cancer - Abstract
Thursday, 10 September 2009
To investigate the relationship between lead and bladder cancer.
read more

Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer - Abstract
Thursday, 10 September 2009
Urology Division, National Cancer Center Hospital, National Cancer Center Research Institute, Tokyo, Japan.
read more

Bladder neck involvement as pT4 disease in prostate cancer: implications for prognosis and patient surveillance - Abstract
Thursday, 10 September 2009
Department of Urology, Hospital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, Créteil, France.
read more

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use? - Abstract
Wednesday, 09 September 2009
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
read more

Confocal laser scanning microscopy of the urothelium - Abstract
Wednesday, 09 September 2009
Urologische Klinik und Poliklinik, Universität Rostock, Ernst-Heydemann-Strrasse 6, 18057, Rostock, Germany.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts